WESAffected

The referring person is referred for the exomin test when he has clinical symptoms suspected of genetic disorders. After obtaining the comprehensive DNA information of the referring person, bioinformatics, artificial intelligence and medical genetics experts will finally identify the desired change by carefully analyzing this information and according to the inheritance pattern of the possible genetic disease. The accurate identification of the genetic changes that cause the disease (single nucleotide changes, deletions and additions) of the referring person makes it possible to ensure whether the fetus is healthy or sick by examining these changes in subsequent pregnancies, and also to provide the best possible prevention and treatment options to the patients. presented